Private Deployment | Compliance By Design | Execution-Ready
Clean, Consented HCP Data for Pharma Grade Marketing
Fix broken CRM data, enable compliant outreach, and prepare for DPDP without rebuilding your entire tech stack. Multiplier AI helps pharmaceutical and highly regulated organizations cleanse, structure, and activate HCP data with explicit consent, domain intelligence, and regulatory safety built in.
Trusted By Global Life Sciences & Pharma for their Most Valuable Brands
The Real Problem
DPDP Is Not The Root Cause. CRM Chaos Is.
Most Pharmaceutical Companies Do Not Suffer From A DPDP Implementation Problem.
They Suffer From A Data Problem.
CRM systems are inconsistent, outdated, and fragmented:
HCP names, specialties, locations, & attributes
do not match
Data is not refreshed periodically
Medical reps, marketing
teams, & external sources all feed data differently
There is no single, reliable source of truth
Because pharma organizations are not heavy technology investors, this problem compounds over years. The result is relationship-based marketing only. Outbound or scalable engagement becomes nearly impossible.
DPDP did not create this issue. DPDP exposed it.
What Breaks In Pharma Today
01
- CRM data is irregular, inconsistent, and ungoverned
- No reliable way to create new HCP contacts compliantly
- Scraping or buying data creates immediate DPDP violations
- Consent does not exist or cannot be proven
- Any regulatory change takes years to respond to internally
02
For Listed Pharma Companies, Even A Small Mistake Can Mean:
- Regulatory penalties
- Product withdrawals
- Reputation damage that cannot be reversed
The Multiplier AI Solution
Pharma-Safe Data Cleansing and Consent Infrastructure
Multiplier AI is not a generic marketing platform.
It is a pharma-grade data cleansing and
consent creation system, built with one goal:
to make HCP data usable, compliant, and safe for outreach.
Instead of rebuilding CRMs or experimenting with vendors who do not understand pharma, Multiplier provides a ready-to-deploy solution that took years to build.
How It Works
HCP Data Cleansing with Domain Intelligence
Multiplier understands pharma terminology, specialties, hierarchies, and industry-specific nuances that generic data vendors cannot.
Consent Creation, Not Data Scraping
New HCP data is created through compliant, consent-driven workflows. No scraping. No shortcuts. No regulatory exposure.
Secure Data Operations
Data stays private, controlled, and accessible only within defined boundaries. This is not a shared AI model or open system.
Audit-Ready by Default
Every data action, consent event, and interaction is logged and defensible.
Why Multiplier AI Exists
Problems Pharma Cannot Outsource Easily
Pharma Companies Face Impossible Choices:
- Tech vendors who understand data but not pharma
- Pharma vendors who understand the industry but not data engineering
- AI tools that require sharing private, regulated data
This work would take most organizations five years. Multiplier delivers it as a plug-and-play capability.
Multiplier AI exists because:
HCP data is domain-specific
Consent is non-negotiable
Data cannot leave controlled environments
Internal teams cannot prioritize multi-year data cleansing projects
Who This Is For
Multiplier AI is built for highly regulated, reputation-sensitive organizations, including:
Security, Governance, & Trust
Multiplier AI is built for highly regulated, reputation-sensitive organizations, including:
Explicit,
provable consent tracking
provable consent tracking
Purpose limitation and
controlled usage
controlled usage
Data minimization and
retention enforcement
retention enforcement
Immutable audit trails
Strict role-based access
Business Impact
What Changes After Multiplier AI
- CRM data becomes usable and trustworthy
- Outbound HCP engagement becomes possible again
- DPDP readiness without disruption
- Reduced dependency on unsafe vendors and practices
- Confidence to scale without reputational fear
Compliance Becomes A Foundation, Not A Bottleneck.
The Timing Is Critical
Pharma globally has already lived through:
India Is Behind By Years, Not By Choice, But By Timing.
Sunshine Act enforcement
HIPAA failures
Public regulatory penalties
DPDP Is The Beginning, Not The End.
Organizations That Act Now Will Avoid The Failures Others Have Already Experienced Globally. Those That Wait Will Be Forced To React Under Scrutiny.